➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Medtronic
McKinsey
Colorcon
McKesson
Express Scripts
Mallinckrodt

Last Updated: July 14, 2020

DrugPatentWatch Database Preview

TEMOVATE E Drug Profile


Email this page to a colleague

» See Plans and Pricing

« Back to Dashboard

When do Temovate E patents expire, and when can generic versions of Temovate E launch?

Temovate E is a drug marketed by Fougera Pharms and is included in one NDA.

The generic ingredient in TEMOVATE E is clobetasol propionate. There are fourteen drug master file entries for this compound. Fifty-three suppliers are listed for this compound. Additional details are available on the clobetasol propionate profile page.

US ANDA Litigation and Generic Entry Outlook for Temovate E

A generic version of TEMOVATE E was approved as clobetasol propionate by COSETTE on February 16th, 1994.

  Start Trial

Summary for TEMOVATE E
Drug patent expirations by year for TEMOVATE E
Recent Clinical Trials for TEMOVATE E

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
VA Office of Research and DevelopmentN/A
University Hospitals Cleveland Medical CenterN/A
GlaxoSmithKlinePhase 2

See all TEMOVATE E clinical trials

US Patents and Regulatory Information for TEMOVATE E

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Fougera Pharms TEMOVATE E clobetasol propionate CREAM;TOPICAL 020340-001 Jun 17, 1994 DISCN Yes No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Medtronic
McKinsey
Colorcon
McKesson
Express Scripts
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.